Research on Large Endothelial Cell-Derived Extracellular Vesicles in Pediatric Obstructive Sleep Apnea Syndrome

Area of Science:

• Cardiovascular Biology
• Sleep Medicine
• Extracellular Vesicles Research

Background:

• Obstructive sleep apnea (OSA) is a prevalent condition in children with potential long-term health consequences.
• Endothelial dysfunction is implicated in OSA pathogenesis.
• Extracellular vesicles (EVs) are emerging as potential biomarkers for various diseases.

Purpose of the Study:

• To investigate the association between clinical indicators of obstructive sleep apnea (OSA) and large endothelial cell-derived extracellular vesicles (large endothelial EVs) in children.
• To explore the potential of these EVs as biomarkers for OSA severity.

Main Methods:

• 81 children with OSA were enrolled (29 mild, 52 moderate-to-severe).
• Levels of CD31+CD41- and CD62E large endothelial EVs were measured.
• Receiver operating characteristic (ROC) curves assessed discriminatory ability for OSA severity.
• Spearman correlation and multiple regression analyses evaluated associations with clinical parameters (e.g., OAHI, sleep efficiency).

Main Results:

• CD31+CD41- large endothelial EVs were significantly elevated in children with moderate-to-severe OSA compared to mild OSA (p<0.05).
• ROC analysis showed CD31+CD41- EVs had good discriminatory power (AUC=0.848, sensitivity 82.8%, specificity 75%).
• CD31+CD41- EVs positively correlated with Obstructive Apnea-Hypopnea Index (OAHI) and negatively with sleep efficiency (p<0.05).

Conclusions:

• CD31+CD41- large endothelial EVs are closely associated with OSA severity indicators, including OAHI and sleep efficiency.
• These EVs show potential as a biomarker for assessing OSA severity in children.
• Further prospective validation is necessary for clinical application.